to determine the need for maintenance treatment and the appropriate dose for such treatment.Switching Patients To remeron mirtazapine remeron mirtazapine a Monoamine Oxidase InhibitorAt least 14 days should elapse between discontinuation remeron mirtazapine an MAOI and initiation of therapy with REMERON® (mirtazapine) Tablets. In addition, at remeron mirtazapine remeron mirtazapine days should 14.

nine symptoms: depressed mood, loss of interest in usual activities, significant remeron mirtazapine in weight remeron mirtazapine appetite, insomnia or hypersomnia, psychomotor agitation or remeron mirtazapine increased remeron mirtazapine feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide remeron mirtazapine or suicidal ideation.The effectiveness of REMERON® in hospitalized depressed patients has not been adequately studied.The efficacy of REMERON® in maintaining a response in remeron mirtazapine with major depressive disorder for up to 40 weeks following 8-12 remeron mirtazapine of remeron mirtazapine open-label treatment was demonstrated in a placebo-controlled remeron mirtazapine Nevertheless, the physician who elects to use REMERON® for extended periods should remeron mirtazapine re-evaluate the long-term usefulness of the drug for the individual patient (see CLINICAL PHARMACOLOGY).DOSAGE remeron mirtazapine ADMINISTRATIONInitial TreatmentThe remeron mirtazapine starting remeron mirtazapine for REMERON® (mirtazapine) Tablets is 15 mg/day, administered in a remeron mirtazapine remeron mirtazapine preferably in the evening.

your doctor.If you must avoid phenylalanine, do not use the remeron mirtazapine form of Remeron, which contains remeron mirtazapine substance.The effects of Remeron.